Francesco Bandello is Professor and Chairman of the Department of Ophthalmology at the University VitaSalute, Milan, Italy. He is a member of the Academia Ophthalmologica Internationalis and the Vice President of Academia Ophthalmologica Europea. He has been a peer reviewer for National Institutes of Health grant applications.
Professor Bandello is Editor-in-Chief of the European Journal of Ophthalmology and Editor of Developments in Ophthalmology. He also serves on the Editorial Boards of several other ophthalmology journals.
Professor Bandello's scientific interests include the study of new therapeutic agents for the inhibition of angiogenesis in cases of proliferative diabetic retinopathy and age-related macular degeneration (AMD), biomarkers in AMD, and the correlation between systemic and ophthalmic vascular diseases. He is also interested in medical robotics and bioengineering in the study of the retina.
Professor Bandello has been the principal investigator in several clinical trials concerning diabetic retinopathy and AMD. He is co-author of nine books and has published 651 articles in journals listed on PubMed relating to retinal diseases, diabetic retinopathy, AMD, and fluorescein and indocyanine green angiographies of different retinal vascular disorders.
"The XOVA program is an extraordinary opportunity to improve human quality of life and vision in developing areas, and create a community of people attentive to those most in need. I'm proud to be a XOVA judge."